Wasatch Core Growth Fund’s Q1 2021 Investor Letter
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 5.59% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell 2000 Index, that increased 12.70% and the Russell 2000 Growth Index that rose 4.88% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Published on May 10, 2021 at 11:14 am by Inan Dogan, PhD
Warren Buffett never mentions this but he is one of the first hedge fund managers who unlocked the secrets of successful stock market investing. He launched his hedge fund in 1956 with $105,100 in seed capital. Back then they weren’t called hedge funds, they were called “partnerships”. Warren Buffett took 25% of all returns in excess of 6 percent.
Is Allegiant Travel Company (ALGT) A Smart Long-Term Buy?
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 5.59% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell 2000 Index, that increased 12.70% and the Russell 2000 Growth Index that rose 4.88% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Wasatch Global Investors, in its Q1 2021 investor letter, mentioned Allegiant Travel Company (NASDAQ: ALGT), and shared their insights on the company. Allegiant Travel Company is a Las Vegas, Nevada-based travel and hospitality company that currently has a $3.6 billion market capitalization. Since the beginning of the year, ALGT delivered an 18.76% return, impressively extending its 12-month gains to 204.53%. As of May 07, 2021, the stock closed at $224.74 per share.
Ensign Group (ENSG), Wasatch Global’s 2nd-Best Q1 2021 Contributor
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 5.59% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell 2000 Index, that increased 12.70% and the Russell 2000 Growth Index that rose 4.88% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Wasatch Global Investors, in its Q1 2021 investor letter, mentioned The Ensign Group, Inc. (NASDAQ: ENSG), and shared their insights on the company. The Ensign Group, Inc. is a Mission Viejo, California-based home health care services company that currently has a $4.7 billion market capitalization. Since the beginning of the year, ENSG delivered an 18.40% return, extending its 12-month gains to 130.92%. As of May 07, 2021, the stock closed at $86.34 per shar
Five9 Inc. (FIVN) Performed Poorly, Became a Detractor in Wasatch Global’s Q1 Portfolio
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 5.59% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell 2000 Index, that increased 12.70% and the Russell 2000 Growth Index that rose 4.88% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Wasatch Global Investors, in its Q1 2021 investor letter, mentioned Five9, Inc. (NASDAQ: FIVN), and shared their insights on the company. Five9, Inc. is a San Ramon, California-based software company that currently has an $11.4 billion market capitalization. Since the beginning of the year, FIVN delivered a -2.44% return, while its 12-month gains are up by 61.76%. As of May 07, 2021, the stock closed at $170.14 per share.
Here’s Why Ligand Pharmaceuticals (LGND) Became Wasatch Global’s Q1 2021 Top Contributor
Wasatch Global Investors, an investment management firm, published its “Wasatch Core Growth Fund” first quarter 2021 investor letter – a copy of which can be downloaded here. A return of 5.59% was recorded by the fund for the Q1 of 2021, trailing the benchmark, Russell 2000 Index, that increased 12.70% and the Russell 2000 Growth Index that rose 4.88% for the same period. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.
Wasatch Global Investors, in its Q1 2021 investor letter, mentioned Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), and shared their insights on the company. Ligand Pharmaceuticals Incorporated is a San Diego, California-based biopharmaceutical company that currently has a $2.1 billion market capitalization. Since the beginning of the year, LGND delivered a 31.34% return, while its 12-month gains are up by 26.77%. As of May 07, 20